Ledger.Open graph →
SEC Form D · Amendment · filed December 8, 2014

Transplant Genomics Inc

Offering
$1.7M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Other
Location
BROOKLINE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Daniel Salomon · Brookline, MADirectorMichael Abecassis · Brookline, MADirectorStanley Rose · Brookline, MAExec · DirectorFaouzi Sefrioui · Woodinville, WADirectorVernon W. Bryant, Jr · Fort Worth, TXExec · DirectorJohn P. Talbott · Bondi, Channel IslandsDirectorSaladin El Ayoubi · Seattle, WADirectorJeffrey P. Beyer · Portland, ORDirectorLisanne T. Davidson · Fort Worth, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗